On April 30, 2026, shares of RPG Life Sciences, a pharmaceutical company, surged by 14% to reach an intraday high of ₹2,312.4 following the announcement of its fourth quarter earnings and a proposed dividend. The stock has rebounded 33.43% from its 52-week low of ₹1,733 recorded on March 23, 2026. Despite a general market decline, RPG Life Sciences saw strong demand, with shares trading at ₹2,250, up 10.81% from the previous close. The company's profit after tax (PAT) for Q4FY26 was ₹30 crore, a significant decrease of 74.42% year-on-year, although it represented a 35.54% increase from the previous quarter. Revenue from operations for the quarter stood at ₹176.89 crore, reflecting a 23.61% year-on-year increase but a slight decline from the previous quarter. The board has recommended a dividend of ₹24 per share, subject to approval at the upcoming Annual General Meeting, with a record date set for June 19, 2026.